Company Ibnsina Pharma

ISPH

EGS512O1C012

Drug Retailers

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Ibnsina Pharma

EPS Revisions

Annual profits - Rate of surprise

Sector Other Drug Retailers

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
2.37 ^EGP	-7.06%		-18.28%	-24.52%

Mar. 03	Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 05	Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index	CI

Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.

Number of employees: 5,500

EGP in Million	2022	Weight	2023	Weight	Delta
Medical and Semi-medical Products 100.0 %	22,264	100.0 %	33,949	100.0 %	+52.48%

EGP in Million	2022	Weight	2023	Weight	Delta
Egypt 100.0 %	22,264	100.0 %	33,949	100.0 %	+52.48%

Managers	Title	Age	Since
Omar Mohammad Abdel Gawad Mahmoud CEO	Chief Executive Officer	-	00-12-17
Mahmoud Mohammad Abdel Gawad Mahmoud CEO	Chief Executive Officer	-	00-12-17
Momen Gomaa DFI	Director of Finance/CFO	-	-
Amro Mohammad Adli Khorshid CTO	Chief Tech/Sci/R&D Officer	-	-
Mohammed Mohsin Mohammed Mahjoub BRD	Director/Board Member	-	-
Mohamed Mahmoud Shawky IRC	Investor Relations Contact	-	17-10-31
Mohamed Adel Abdul Karim PRN	Corporate Officer/Principal	-	-
Rabeea Marzouk Kamaluddin Ruslan SAM	Sales & Marketing	-	-
Ahmed Refaat HRO	Human Resources Officer	-	12-12-31

Members of the board	Title	Age	Since
Mahmoud Mohammad Abdel Gawad Mahmoud CEO	Chief Executive Officer	-	00-12-17
Omar Mohammad Abdel Gawad Mahmoud CEO	Chief Executive Officer	-	00-12-17
Mohammed Mohsin Mohammed Mahjoub BRD	Director/Board Member	-	-
Hany Hasanen Mohammad Bader BRD	Director/Board Member	-	-
Mohammad Mohammad Mohsen Mahjoub BRD	Director/Board Member	-	-
Mohammad Abbas Mohammad Abbas Zaki BRD	Director/Board Member	-	-
Abdel Aziz Ali Abdel Aziz CHM	Chairman	-	-
Ahmad Mahmoud Abdel Jawad Mahmoud BRD	Director/Board Member	-	-
Ahmad Fathi Abdel Rahman Al-Nawawi BRD	Director/Board Member	-	-
Huda Hasan Amin Wali BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,008,000,000	618,896,741 ( 61.40 %)	0	61.40 %

Name	Equities	%	Valuation
Abdel Gawad Family 13.51 %	151,286,616	13.51 %	8 M £
Mahgoub Family 13.01 %	145,683,408	13.01 %	8 M £
FAISAL ISLAMIC BANK OF EGYPT 12.59 %	140,981,175	12.59 %	8 M £
European Bank for Reconstruction & Development 8.712 %	97,577,842	8.712 %	5 M £
Silk Invest Ltd. 0.4433 %	4,964,881	0.4433 %	268 153 £
Duet Asset Management Ltd. 0.1446 %	1,619,144	0.1446 %	87 450 £
Abdel Aziz Ali Abdel Aziz 0.1358 %	1,521,500	0.1358 %	82 176 £
S-Bank Fund Management Ltd. 0.0693 %	776,066	0.0693 %	41 915 £
Invest AD Asset Management PJSC 0.0429 %	480,790	0.0429 %	25 967 £
Ashburton Fund Managers (Pty) Ltd. 0.0315 %	352,709	0.0315 %	19 050 £

Ibnsina Pharma

Industrial Zone 1, Plot 2-3 Block 12-15

, Obour City

http://www.ibnsina-pharma.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.43 EGP

Average target price

4.082 EGP

Spread / Average Target

+68.00%

Consensus

Estimates Revisions

Company calendar

Consumer Non-Cyclicals

Food & Drug Retailing

Food & Drug Retailing

Drug Retailers

Other Drug Retailers

	1st Jan change	Capi.
IBNSINA PHARMA	-24.52%	51.19M
WALGREENS BOOTS ALLIANCE, INC.	-33.59%	14.96B
JD HEALTH INTERNATIONAL INC.	-24.42%	11.07B
YIFENG PHARMACY CHAIN CO., LTD.	+9.74%	6.13B
MATSUKIYOCOCOKARA & CO.	-10.37%	5.98B
NAHDI MEDICAL COMPANY	+0.88%	4.76B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+53.60%	4.36B
CLICKS GROUP LIMITED	-10.49%	3.73B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-12.53%	3.43B
WELCIA HOLDINGS CO., LTD.	-7.34%	3.02B

Other Drug Retailers